ANTIPYRINE PLASMA HALF-LIFE - INVIVO INDICATOR OF OXIDATIVE METABOLIC CAPABILITY IN RHESUS-MONKEYS (MACACA-MULATTA)

被引：17

作者：

MILLER, JL ^{[1
]}

CLARK, CR ^{[1
]}

GEE, SJ ^{[1
]}

KRIEGER, RI ^{[1
]}

机构：

[1] UNIV CALIF DAVIS,DEPT ENVIRONM TOXICOL,DAVIS,CA 95616

来源：

PHARMACOLOGY | 1978年 / 16卷 / 05期

关键词：

D O I：

10.1159/000136780

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：279 / 286

页数：8

共 31 条

[1] DEVELOPMENT AND EVALUATION OF METHOD FOR SIMULTANEOUS DETERMINATION OF PHENOBARBITAL AND DIPHENYLHYDANTOIN IN PLASMA BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].

ATWELL, SH ;

GREEN, VA ;

HANEY, WG .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (05) :806-809

[2]

BAKKE OM, 1974, ACTA PHARMACOL TOX, V35, P91

[3] NORPHENAZONE, A NEW METABOLITE OF PHENAZONE IN HUMAN URINE [J].

BATY, JD ;

PRICEEVA.DA .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (01) :83-84

[4] INCREASED CLEARANCE OF ANTIPYRINE AND D-PROPRANOLOL AFTER PHENOBARBITAL TREATMENT IN MONKEY - RELATIVE CONTRIBUTIONS OF ENZYME-INDUCTION AND INCREASED HEPATIC BLOOD-FLOW [J].

BRANCH, RA ;

SHAND, DG ;

WILKINSON, GR ;

NIES, AS .

JOURNAL OF CLINICAL INVESTIGATION, 1974, 53 (04) :1101-1107

[5]

BRECKENRIDGE A, 1972, CLIN PHARMAC THER, V14, P514

[6]

BRODIE BB, 1949, J BIOL CHEM, V179, P25

[7]

BRODIE BB, 1950, J PHARMACOL EXP THER, V98, P97

[8]

BURNS JJ, 1966, C NONHUMAN PRIMATE T, P66

[9]

DAVIES DS, 1973, DRUG METAB DISPOS, V1, P411

[10] MECHANISM OF HEPATIC DRUG OXIDATION AND ITS RELATIONSHIP TO INDIVIDUAL DIFFERENCES IN RATES OF OXIDATION IN MAN [J].

DAVIES, DS ;

THORGEIRSSON, SS .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1971, 179 (JUL6) :411-+

← 1 2 3 4 →